Cargando…
Tocilizumab as a possible cause of ischemic colitis()
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier España, S.L.U.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071474/ http://dx.doi.org/10.1016/j.gastre.2020.07.011 |
| _version_ | 1783683714249654272 |
|---|---|
| author | Forneiro Pérez, Rocío Dabán López, Pablo Zurita Saavedra, María Sol Hernández García, María Dolores Mirón Pozo, Benito |
| author_facet | Forneiro Pérez, Rocío Dabán López, Pablo Zurita Saavedra, María Sol Hernández García, María Dolores Mirón Pozo, Benito |
| author_sort | Forneiro Pérez, Rocío |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8071474 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80714742021-04-26 Tocilizumab as a possible cause of ischemic colitis() Forneiro Pérez, Rocío Dabán López, Pablo Zurita Saavedra, María Sol Hernández García, María Dolores Mirón Pozo, Benito Gastroenterología y Hepatología (English Edition) Scientific Letter Elsevier España, S.L.U. 2021-05 2021-04-25 /pmc/articles/PMC8071474/ http://dx.doi.org/10.1016/j.gastre.2020.07.011 Text en © 2020 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Scientific Letter Forneiro Pérez, Rocío Dabán López, Pablo Zurita Saavedra, María Sol Hernández García, María Dolores Mirón Pozo, Benito Tocilizumab as a possible cause of ischemic colitis() |
| title | Tocilizumab as a possible cause of ischemic colitis() |
| title_full | Tocilizumab as a possible cause of ischemic colitis() |
| title_fullStr | Tocilizumab as a possible cause of ischemic colitis() |
| title_full_unstemmed | Tocilizumab as a possible cause of ischemic colitis() |
| title_short | Tocilizumab as a possible cause of ischemic colitis() |
| title_sort | tocilizumab as a possible cause of ischemic colitis() |
| topic | Scientific Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071474/ http://dx.doi.org/10.1016/j.gastre.2020.07.011 |
| work_keys_str_mv | AT forneiroperezrocio tocilizumabasapossiblecauseofischemiccolitis AT dabanlopezpablo tocilizumabasapossiblecauseofischemiccolitis AT zuritasaavedramariasol tocilizumabasapossiblecauseofischemiccolitis AT hernandezgarciamariadolores tocilizumabasapossiblecauseofischemiccolitis AT mironpozobenito tocilizumabasapossiblecauseofischemiccolitis |